BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10761566)

  • 1. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome.
    Camp-Sorrell D
    Oncol Nurs Forum; 2008 Jul; 35(4):593-6. PubMed ID: 18591164
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
    Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mitomycin-induced hemolytic-uremic syndrome].
    Zeller G; Wandel E; Schwarting A
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
    Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
    Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug induced hemolytic uremic syndrome].
    Ito K; Komatsu Y
    Nihon Rinsho; 1993 Jan; 51(1):204-9. PubMed ID: 7679450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrent hemolytic uremic syndrome induced by pranoprofen].
    Okura H; Hino M; Nishiki S; Kono K; Hasegawa T; Nakamae H; Ohta K; Yamane T; Takubo T; Tatsumi N
    Rinsho Ketsueki; 1999 Aug; 40(8):663-6. PubMed ID: 10496042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin-C induced hemolytic uremic syndrome: a case report.
    Gundappa RK; Sud K; Kohli HS; Gupta KL; Joshi K; Sakhuja V
    Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of mitomycin C nephropathy.
    Motoo Y; Sawabu N; Ikeda K; Takemori Y; Ohta H; Okai T; Yokoyama H
    Intern Med; 1994 Mar; 33(3):180-4. PubMed ID: 8061399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome presenting after treatment of endodermal sinus tumor.
    Ogunleye DA; Lewin SN; Mutch DG; Liapis H; Herzog TJ
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1184-7. PubMed ID: 15516446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
    Shah R; Beem E; Sautina L; Zharikov SI; Segal MS
    Nephrol Dial Transplant; 2007 Feb; 22(2):617-20. PubMed ID: 17041000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.